Damora grants 453,500 options to new hires
Damora Therapeutics granted inducement stock options to nine new employees on July 1, 2026. The options cover 453,500 shares with an exercise price of $26.01 per share and a 10-year term. Vesting begins after one year.
*this image is generated using AI for illustrative purposes only.
Damora Therapeutics granted equity awards to nine newly-hired, non-executive employees on July 1, 2026. The awards were approved by the independent Compensation Committee of its Board of Directors and were made as material inducements to employment in accordance with Nasdaq Listing Rule 5635(c)(4). The grants aim to attract talent to the biotechnology company focused on blood disorders.
The inducement grants consist of non-qualified stock options to purchase an aggregate of 453,500 shares of Damora’s common stock. The options have a 10-year term and an exercise price of $26.01 per share. All options vest as to 25% on the first anniversary of the employees’ start date and in equal monthly installments for the following 36 months.
Grant Details
| Metric | Details |
|---|---|
| Total Shares Granted | 453,500 |
| Exercise Price | $26.01 per share |
| Term | 10 years |
| Vesting Schedule | 25% on first anniversary, then monthly for 36 months |
The grants are subject to the terms and conditions of the 2022 Damora Therapeutics, Inc. Inducement Plan and the applicable stock option award agreement. Damora Therapeutics is advancing biologics to treat mutant calreticulin-driven myeloproliferative neoplasms, with programs on track to enter clinical development in 2026.
How will these equity awards impact Damora's cash burn rate and financial runway as it approaches clinical trials in 2026?
What specific roles do these nine new hires fill, and how critical are they to the upcoming clinical development programs?
Could this hiring spree signal an acceleration of Damora's timeline for entering clinical development?
17
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
